CAPD: Clinical Trials

4 trials for CAPD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1
Phase 31Completed 1
Phase 41Completed 1

Follow CAPD: new trials by email Literature Review of CAPD trials Research Report on CAPD

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially)
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver3442025-03-312026-04-30
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
Dianeal, Dianeal, Extraneal, Nutrineal - End Stage Renal Disease (ESRD), Diabetes
Phase 3CompletedVantive Health LLC712010-10-012025-07-24
BIOmarkers of Dyspnea IN Emergency Room
Prognostic value of Biomarkers - Severe Dyspnea, CAPD
CompletedThermoFisher Scientific Brahms Biomarkers France4442010-04-012011-12-07
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
Physioneal, Dianeal, Extraneal - ESRD, Diabetes
Phase 4CompletedVantive Health LLC1372008-01-012025-07-22

Narrower conditions

Diabetes Mellitus (2)  ·  Kidney Failure, Chronic (2)  ·  Auditory Diseases, Central (1)  ·  Dyspnea (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sensorineural (1)  ·  Language Development Disorders (1)  ·  Presbycusis (1)  ·  Pulmonary Embolism (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Glucose Metabolism Disorders (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)  ·  Renal Insufficiency (2)  ·  Renal Insufficiency, Chronic (2)  ·  Signs and Symptoms (2)

Interventions

Icodextrin (2)  ·  Nutrineal (2)  ·  Clemastine (1)  ·  Placebo Effect (1)

Sponsors

Vantive Health LLC (2)  ·  ThermoFisher Scientific Brahms Biomarkers France (1)  ·  University of Colorado, Denver (1)

Countries

Colombia (1)  ·  France (1)  ·  Hong Kong (1)  ·  Russia (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Achim Klug, PhD (1)  ·  Arnaud Martinage, Dr (1)  ·  Eric Weil, Pr (1)  ·  Fatima Rayeh, Dr (1)  ·  Guillaume Der Sahakian, Dr (1)  ·  Pierre Hausfater, Pr (1)  ·  Samuel A Budoff, PhD, MS (1)  ·  Yann-Erick Claessens, Dr (1)